Background: Matrix metalloproteinase (MMP) inhibitors decrease inflammation in normal tissues and suppress cancer progress in normal tissues. Valproic acid (VA) and doxycycline (DX) are MMP inhibitors that have radio-protective effects. Their ability to inhibit MMPs in irradiated tissue is unknown and the role of MMPs in radio-protective effects has not been tested to date. Aims: The purpose of this study was to examine whether administration of VA and DX to rats before irradiation affects tissue inflammation and apoptosis in the early phase of radiation, and whether the effect of these drugs is mediated by MMP inhibition. Study Design: Animal experimentation. Methods: Twenty-six Wistar rats were randomized into four groups: control (CTRL), radiation (RT), VA plus radiation (VA+RT), and DX plus radiation (DX+RT). Three study groups were exposed to a single dose of abdominal 10 Gy gamma radiation; the CTRL group received no radiation. Single doses of VA 300 mg/kg and DX 100 mg/kg were administered to each rat before radiation and all rats were sacrificed 8 hours after irradiation, at which point small intestine tissue samples were taken for analyses. Levels of inflammatory cytokines (TNF-α, IL-1β, and IL-6) and matrix metalloproteinases (MMP-2 and MMP 9) were measured by ELISA, MMP activities were measured by gelatin and casein zymography and apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling assay. Results: VA decreased the levels of TNF-α and IL-1β proteins insignificantly and decreased apoptosis significantly in the irradiated tissue, but did not inhibit MMPs. In contrast, VA protected the basal MMP activities, which decreased in response to irradiation. No effect of DX was observed on the levels of inflammatory cytokines or activities of MMPs in the early phases of radiation apoptosis. Conclusion: Our findings indicated that VA protects against inflammation and apoptosis, and DX exhibits anti-apoptotic effects in early radiation and these effects are independent from MMP inhibition.
During tumor ablation with radiotherapy, injury of the surrounding healthy tissue leads to considerable side effects. Radiotherapy of abdominopelvic tumors frequently damages the small intestine. Acute radiation damage in the small intestine begins within hours, with the activation of transcription factors, inflammatory cytokines, and apoptosis leading to mucosal degradation (1, 2) .
Matrix metalloproteinases (MMPs) play a critical role in tissue remodeling by degrading the matrix and connective tissue proteins. In pathological situations such as radiation damage protein levels of MMPs are increased (3) . Levels of inflammatory cytokines and activities of MMPs are elevated concomitantly in the acute phase of radiation-induced intestinal inflammation (4) . MMPs can aggravate or suppress inflammation by enzymatically changing the structure and function of inflammatory substrates (5, 6) .
Tetracycline derivatives are antimicrobial agents that have MMP inhibitory effects. Doxycycline (DX) is the strongest non-specific MMP inhibitor known within this group. Through MMP-2 and MMP-9 inhibition, DX reduces cell invasion and migration in cancer cells, and elicits anti-inflammatory features in normal tissues (7, 8) .
Valproic acid (VA), which is used as a treatment for epilepsy, is a class 1 histone deacetylase inhibitor. VA has anti-inflammatory effects, mediated by MMP-9 inhibition (9) . Similarly to DX, VA has anti-cancer effects, mediated by inhibition of MMP-2 and MMP-9 (10) . Radiation injury experiments indicate that VA and DX elicit radioprotective effects through various mechanisms (11, 12) . However, the effect of VA and DX on MMP inhibition has not been tested before in radiationdamaged tissue. The purpose of this study was to examine the effects of VA and DX on tissue inflammation and apoptosis associated with MMP during early radiation damage.
VA and DX have useful effects on radiation damage, inflammation, and cancer processes and also have low toxicity and are low cost. Therefore, their effectiveness in radiotherapy is of interest. This is the first study to examine the radio-protective effectiveness of VA and DX in vivo in relation to MMPs in the first hours of radiation damage.
MATERIALS AND METHODS
Experimental groups, irradiation, and drug treatment For this study, 26 Wistar albino male rats weighing 250-300 g were supplied by the Dokuz Eylül University Animal Laboratory. The experiments were conducted under non-sterile, clean conditions at room temperature. The rats were kept in standard laboratory conditions, with a 12-hour dark and light cycle and free access to water and food. All experimental procedures were conducted according to the NIH Guide for the Care and Use of Laboratory Animals (1985) . The experiments were approved by the Dokuz Eylül University Ethics Committee for Animal Experimentation.
Radiation, drug medication and tissue collection were performed under anesthesia, and all efforts were made to minimize the suffering of animals. The rats were randomly divided into four groups: Control (CTRL) group (n=5), radiotherapy (RT) group (n=7), VA+RT (n=7), and DX+RT group (n=7). The CTRL group was not treated with any drug or radiation. In the other three groups, a single dose of 10 Gy gamma radiation was delivered to the abdominal region. The radiation treatment was performed at the Dokuz Eylül University Medical School Department of Radiation Oncology. The radiation dose was selected in accordance with those used in a previous study (13) . Radiation was applied by focusing a Theratron Co 60 device generating 1.25 MV photon energy on the skin from a distance of 100 cm, and the dose of radiation was 1 Gy/ min. The drugs were administered 1 hour before exposure to radiation. The RT group received 10 mg/kg physiological saline solution (Biofleks; Biosel İlaç A.Ş, İstanbul, Turkey) via subcutaneous (SC) injection. The VA+RT group received VA. Sodium valproate (Depakin, Sanofi Aventis; İstanbul, Turkey) 400 mg lyophilized powder was mixed with sterile injectable water and 300 mg/kg administered subcutaneously (SC). The DX+RT group received 100 mg/kg intramuscular (IM) DX monohydrate solution (200 mg per mL ready solution for injection) (Doksilin LA, Provet; İstanbul, Turkey). The VA dose required for MMP inhibition was determined on the basis of that reported in a previous study (14) . DX was administered as a single dose of 100 mg/kg since the recommended DX longacting injectable dose was 70-100 mg/kg in rat medication (15) . For anesthesia, an intraperitoneal mixture containing 80 mg/kg ketamine (Ketalar, Pfizer; İstanbul, Turkey) and 7 mg/ kg xylazine (Basilazin 2%; Bavet, İstanbul, Turkey) was used. All rats were sacrificed 8 hours after radiation, and small intestine tissue samples 10 cm away from the ileocecal valve were collected for analyses.
ELISA
Colon tissues (50 mg) were homogenized in lysis buffer (150 mM NaCl, 0.1% SDS, 0.1% NP-40, 20 mM Tris-HCl pH 7.5 and protease inhibitor cocktail) using a Tissue Lyser II homogenizer (Qiagen; Hilden, Germany). Total protein concentrations of tissue homogenates were detected by BCA (bicinchoninic acid) assay (Thermo Scientific; Rockford, IL, USA).
The protein levels of TNF-α (Invitrogen; Carlsbad, CA, USA), IL-1β, IL-6 (Bio Scientific; Austin, TX, USA), MMP-2, and MMP-9 (USCN Life Science Inc.; Wuhan, China) in the tissue samples were determined using commercially availBalkan Med J, Vol. 33, No. 5, 2016 able sandwich ELISA kits, according to the protocol recommended by the manufacturer. Results were recorded using the ratio of detected protein (TNF-α, IL-1β, IL-6, MMP-2, and MMP-9) (pg/mL) to the amount of total protein (µg/mL).
Gelatin and casein zymography assay
Gelatin zymography and casein zymography were performed according to the method of Heussen and Dowdle with some modifications (16) . Tissue samples (50 mg) homogenized with Tissue Lyser II homogenizer (Qiagen; Hilden, Germany) in lysis buffer containing 50 mM Tris-HCl (pH 7.0), 10 mM CaCl 2 , 0.15 M NaCl, 0.05% Brij 35 and total protein concentrations were determined via BCA assay (Thermo Scientific; Rockford, IL, USA). Gelatin zymogram gels containing 1 mg/mL gelatin substrate were used to analyze MMP-2 and MMP-9 activity levels, whereas casein zymogram gels containing 1 mg/mL β-casein substrate were used to detect MMP-7 activity levels. Samples were electrophoretically separated at a constant voltage of 120 V for 2 h at +4°C (Bio-Rad Life Science Hercules; CA, USA) under non-reducing and non-denaturing conditions. The gels were washed twice in 2.5% (v/v) Triton X-100 at room temperature to remove SDS and renature MMPs. Zymogram gels were then incubated overnight at 37°C in a zymogram developing buffer (0.5 M Tris-base, 0.1 M CaCl 2 , 0.5 M NaCl, 0.5% Brij 35, pH 7.6). The gels were stained with 0.5% Coomassie Blue R-250 for 2 hours at room temperature and destained in 20% acetic acid and 40% ethanol in distilled water. Pro-forms and active forms of MMPs were defined as clear bands against a dark background of stained substrate. Recombinant human MMP-2, MMP-7, and MMP-9 proteins (R&D Systems; Minneapolis, MN, USA) were used as positive controls. For densitometry analysis, the area (mm 2 ) and optical density (O.D/mm 2 ) of latent and active bands of MMP-2, MMP-7, and MMP-9 were determined using UVP Bioimaging Systems with LabWorks 4.6 Image Acquisition Software (UVP Inc.; Upland, CA, USA). The activity levels were represented as specific proteinase activity (areaxoptical density/µg of protein).
TUNEL assay
Apoptotic cell death was evaluated by the TUNEL method using an In situ Cell Death Detection Kit, POD (Roche; Mannheim, Germany). Briefly, sections were deparaffinized, rehydrated in graded alcohol, and microwave-pretreated in 0.5% trypsin at 37°C for 30 min. After washing in phosphatebuffered saline, the specimens were incubated with the reaction mixture (TUNEL kits, Roche; Mannheim, Germany) at 37°C for 60 min. After washing, Converter-POD (TUNEL kits, Roche; Mannheim, Germany) was applied to the slides. Sections were stained with diamino benzidine, counter-stained with hematoxylin, and mounted with entellan.
The stained transverse sections were photographed at 40x magnification (Olympus BX-51 Tokyo microscope). Fifty crypts were randomly selected for each group for the photos, and the apoptotic epithelial cells were counted. Apoptotic cells were selected according to the description of Kerr and Negoescu and colleagues (17, 18) . Cells with brown nuclear staining and small apoptotic bodies, which were considered to be derived from a single cell, were counted. The apoptotic index was calculated using the following formula: (number of apoptotic cells/number of total cells)x100.
Statistical analysis
Statistical analyses were performed using GraphPad Prism software version 5.00, Inc. (La Jolla; CA, USA). Multiple groups were compared using the Kruskal-Wallis test. Bonferroni correction with Mann-Whitney U test was performed for comparison of two groups. P values less than 0.0125 were accepted to be statistically significant.
RESULTS
Changes in the levels of inflammatory cytokines and apoptosis in response to radiation, VA, and DX Eight hours after exposure to 10 Gy abdominal gamma radiation, protein levels of TNF-α, IL-6 and IL-1β (CTRL, 0.002±0.0009 pg/µg protein; RT, 0.006±0.001 pg/µg protein, p=0.030; Figure 1a . CTRL, 0; RT, 0.04±0.01 pg/µg protein; p=0.005; Figure 1b . CTRL, 0.05±0.02 pg/µg protein; RT, 0.3±0.09 pg/µg protein;p=0.07; Figue 1c, respectively) were increased compared to the CTRL group. The increases in protein levels of TNF-α and IL-1β were not significant. In the VA+RT group, protein levels of TNF-α, IL-6 and IL-1β were lower in comparison to those in the RT group, but the reductions were not significant (RT, 0.006±0.001 pg/µg; VA+RT, 0.002±0.0007 pg/µg TNF-α; p=0.0303; RT, 0.019±0.003 pg/ µg; VA+RT, 0.010±0.006 pg/µg IL-6; p=0.08; RT, 0.30±0.09 pg/µg; VA+RT, 0.04±0.02 pg/µg IL-1β; p=0.0379, respectively; Figure 1a-c) . In the DX+RT group, there was no significant change in the levels of inflammatory cytokines compared to that in the RT group (RT, 0.006±0.001 pg/µg; DX+RT, 0.007±0.0009 pg/µg TNF-α; p=0.5; RT, 0.019±0.003 pg/µg; DX+RT, 0.02±0.007 pg/µg IL-6; p=0.34; RT, 0.30±0.09 pg/ µg; DX+RT, 0.21±0.07 pg/µg IL-1β; p=0.53, respectively; Figure 1a-c) .
Irradiation resulted in a significant increase in the apoptotic index compared to that observed in the CTRL group (CTRL, 9±2; RT, 12.6±0.7; p=0.0018; Figure 2a,b) . However, apoptosis was significantly lower in both the VA+RT group ( Figure  2c ) and DX+RT group (Figure 2d) Figure 2e) .
Changes in MMP expression and activity in response to
radiation, VA, and DX Eight hours after radiation exposure, the MMP-2 protein level in all groups was the same (Figure 3a) but there was an increase in MMP-9 protein level in the RT group compared to that observed in the CTRL group (CTRL, 0.005±0.002 pg/ µg; RT, 0.1±0.03 pg/µg, p=0.0057; Figure 3b ). In the VA+RT group and DX+RT group, MMP-2 and MMP-9 levels were similar to those in the RT group.
The gelatin zymography assay used to evaluate MMP activity indicated that irradiation significantly decreased the proform of MMP-2 (CTRL, 3514±297; RT, 228±47 in pro-form MMP-2; p=0.0025; Figure 4a ,b). The activity of the MMP-2 active form was below the level of detection in the CTRL group and increased minimally in the RT group (Figure 4a ). MMP-9 pro-and active forms were not observed in the CTRL and RT groups. Using casein zymogram gels, we detected prominent MMP-7 activity in the CTRL group (Figure 4c ). In the RT group, the activities of both the pro-form and the active-form of MMP-7 were significantly suppressed compared to that observed in the CTRL group (CTRL, 1240±173; RT, 11±2 in pro-form MMP-7; p=0.0025 and CTRL, 1841±259; RT, 7±2 in active-form MMP-7; p=0.0025, respectively; Figure 4c and 4d). In the VA+RT group, the activities of the MMP-2 pro-and active forms and MMP-7 pro-and active forms were increased compared to those observed in the RT group, but significant increases were only found in the proand active forms of MMP-7 (RT, 228±47; VA, 758±148 in pro-form MMP-2; p=0.026 and RT, 50±12; VA, 1779±514 in active-form MMP-2; p=0.026, respectively, Figure 4a and 4b and RT, 11±2; VA, 1178±541 in pro-form MMP-7;p=0.0006 and RT, 7±2; VA, 750±253 in active-form MMP-7;p=0.0041, respectively; Figure 4c and 4d). In the DX+RT group, there was no significant difference in activities of MMP-2 and MMP-7 pro-and active forms compared to those in the RT group (Figure 4d ).
DISCUSSION
In our study, we observed increases in the level of inflammatory cytokines after abdominal irradiation. We detected a significant increase in the IL-6 protein level 8 hours after radiation. In irradiated tissues, we observed elevated levels of inflammatory cytokines together with an increased MMP-9 protein level. Previous studies indicated that a single dose of 10 Gy radiation induces MMP-2 and MMP-9 expression in rat brain tissues at 8-24 hours (19) and that preoperative radiotherapy increases MMP-2 and MMP-9 protein levels within a week in rectal mucosa (3). It is clear that the production of inflammatory cytokines and MMPs is induced by radiation soon after exposure. MMP activation is implicated in several physiological and pathological conditions such as remodeling of extracellular matrix, wound healing, tumor progression, uterine involution, bone resorption and intestinal fibrosis as a delayed effect of postradiation injury. Medina and Radomski reported that MMPs are transcriptionally inducible by TNF-α and IL-1β cytokines and that inflammatory cytokine levels together with MMP levels increase in inflammatory bowel disease (20) . The role of MMPs in acute inflammation of intestine subjected to radiation is unknown. It is likely that MMP-2 and MMP-9 expression is triggered by inflammation and/or radiation but the effect on and response of MMPs in irradiated tissue at early stages are unclear.
Strup-Perrot et al. and Hovdenak et al. (4, 21, 22) found increased gelatinolytic activity in acute and late radiation injury but unchanging activity was detected by Kumar in late radiation injury. Another study suggested that MMP-2 activity is suppressed by RECK protein in pancreatic cancer cell lines (23) . This subject is controversial and until the present study there has been no detailed knowledge of how MMP activity is affected during the early acute phases of radiation in intestinal tissue. Therefore we focused on early stage processes. However, after radiation, there was no increase in MMP-9 activity, and a surprising decrease in MMP-2 and MMP-7 activities. The discrepancy between decreased MMP-2, MMP-7 and undetectable MMP-9 activity versus increased MMP-9 expression may be attributed to radiation-induced damage of the MMP protein structure through either a direct or an indirect mechanism, or due to the interaction of MMPs with other inhibitors.
In the current study we reported that attenuated MMP activity is alleviated by VA in irradiated tissue. In addition to this, VA reduced inflammatory cytokine levels but it was statistically insignificant. There is experimental evidence that MMPs can potentiate inflammatory processes by cleavage of chemokines and cytokines or can suppress these processes by degrading them (24, 25) . In an experimental study it was shown that IL-1β stimulated MMP production and furthermore that abundant MMPs were responsible for the degradation of IL-1β (5). In our study MMP activities increased and inflammatory cytokine levels tended to decrease in the VA group while the opposite occurred in the RT group. These results support the notion that MMPs have a degrading effect on inflammatory cytokines in the early phases of radiation and that sustained MMP activity may be in part necessary for the prevention of inflammation and apoptosis.
VA and other histone deacetylase inhibitors were identified as protecting agents against radiation damage because they suppress cutaneous fibrosis and increase wound healing in late phases (11) . Their radio-protective effects have also previously been associated with reduced apoptosis (26) . On the other hand VA has a radio-sensitizing effect on cancer cells through apoptosis induction (27) . Our data on the radio-protective effect of VA are consistent with previous studies. Additionally, our experiment demonstrated the effect of VA on earlier processes following a single prophylactic dose. VA is a promising drug because of its pro-apoptotic effect on cancer cells and anti-apoptotic and anti-inflammatory effects on normal cells in irradiated tissue.
Although DX is a powerful MMP inhibitor, it had no apparent effect on the expression and activity of inflammatory cytokines and MMPs. This may be due to the dose of drug administered or the administration of a single dose. This is consistent with a previous study, in which DX had no MMP inhibitory effect when administered as a 10 mg/kg single dose in vivo (28) . However, in another study, doses of 50 and 500 mg/kg/day had an inhibitory effect on MMP activities (29) . Long-acting injectable DX administered at 70-100 mg/kg SC or IM was recommended for rat antibiotherapy (15) . Since our study aimed to achieve MMP inhibition with a single prophylactic dose of DX before radiation, we used injection as the preferred route of administration. When we administered 100 mg/kg DX via IM, MMP inhibition did not occur; however, apoptosis was suppressed. The anti-apoptotic effect of DX developed independently from its effect on MMP inhibition. The anti-apoptotic mechanism of DX in irradiated tissue needs to be further investigated.
In conclusion, single dose administration of VA and DX before irradiation exhibited a significant radio-protective effect. MMP-2 and MMP-7 activities were decreased 8 hours after radiation damage and reincreased by single dose of VA. Radiation-induced inflammatory cytokines and apoptosis were suppressed by VA simultaneously. VA and DX showed no MMP inhibitory effect in acute radiation damage and their radio-protective effects are unrelated to MMP inhibition. The mechanisms underlying the MMP modulation involved in the radio-protective effect of VA should be addressed in further studies.
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